GEN Exclusives

More »

GEN News Highlights

Back to Item »

Hanmi Licenses Kinex’ Phase II Anticancer Candidate in Select Asian Countries

Src/pretubulin inhibitor is currently in development for treating cancers including prostate, breast, ovarian, and leukemia.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »